Barinthus Biotherapeutics (BRNS)
1.03
0.06 (6.19%)
At close: Jan 15, 2025, 12:05 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -73.63M | 5.32M | -51.11M | -17.93M | -20.82M |
| Depreciation & Amortization | n/a | 4.32M | 602.00K | 208.00K | 346.86K |
| Stock-Based Compensation | 5.05M | 9.88M | 16.49M | 3.63M | n/a |
| Other Working Capital | 3.88M | -183.00K | -63.00K | -32.00K | 924.57K |
| Other Non-Cash Items | 14.57M | -24.09M | 8.74M | 3.64M | -2.55M |
| Deferred Income Tax | -3.09M | -4.34M | -119.00K | -2.49M | n/a |
| Change in Working Capital | 6.17M | -5.52M | -7.18M | 1.92M | 2.94M |
| Operating Cash Flow | -50.92M | -14.43M | -32.58M | -11.03M | -18.76M |
| Capital Expenditures | -5.41M | -6.14M | -1.15M | -293.00K | -128.35K |
| Acquisitions | n/a | 387.76K | -11.77M | 252.89K | 2.06M |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -5.41M | 240.00 | n/a | -252.89K | n/a |
| Investing Cash Flow | -5.41M | -5.75M | -12.91M | -293.00K | 1.93M |
| Debt Repayment | n/a | -159.00K | n/a | 41.24M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -163.00K | n/a | 119.97M | 194.00K | n/a |
| Financial Cash Flow | 1.87M | 325.00K | 222.74M | 41.44M | 1.00 |
| Net Cash Flow | -52.30M | -19.67M | 170.79M | 31.83M | -16.83M |
| Free Cash Flow | -56.34M | -20.57M | -33.73M | -11.32M | -18.89M |